Erratum: Trop-2 is a determinant of breast cancer survival (PLoS ONE (2014)9:5 (e96993) DOI: 10.1371/journal.pone.0096993);Trop-2 is a determinant of breast cancer survival

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Ambrogi, Federico ^a   Fornili, Marco ^a   Boracchi, Patrizia ^a   Trerotola, Marco ^b   Relli, Valeria ^b   Simeone, Pasquale ^b   La Sorda, Rossana ^b   Lattanzio, Rossano ^b   Querzoli, Patrizia ^c   Pedriali, Massimo ^c   Piantelli, Mauro ^b   Biganzoli, Elia ^a,d   Alberti, Saverio ^b,e  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e Oncoxx Biotech srl   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; PROTEIN ANTIBODY; TROP 2 ANTIBODY; TROP 2 PROTEIN; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; TACSTD2 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER MODEL; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CASE STUDY; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR INVASION; ADULT; AGED; BREAST; BREAST TUMOR; DISEASE COURSE; FEMALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BREAST; BREAST NEOPLASMS; CELL ADHESION MOLECULES; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84901250001     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110606     Document Type: Erratum

References (32)

1. Ambrogi F, Biganzoli E, Querzoli P, Ferretti S, Boracchi P, et al. (2006) Molecular subtyping of breast cancer from traditional tumor marker profiles using parallel clustering methods. Clin Cancer Res 12: 781-790. (Pubitemid 43259858)
2. Cimoli G, Malacarne D, Ponassi R, Valenti M, Alberti S, et al. (2004) Meta-analysis of the role of p53 status in isogenic systems tested for sensitivity to cytotoxic antineoplastic drugs. Biochim Biophys Acta 1705: 103-120. (Pubitemid 39592899)
3. Biganzoli E, Pedriali M, Querzoli P, Nenci I, Iacobelli S, et al. (2010) Sentinel Node and Bone Marrow Micrometastases and Nanometastases. Curr Breast Cancer Rep 2: 96-106.
4. Tinari N, Lattanzio R, Natoli C, Cianchetti E, Angelucci D, et al. (2006) Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival. Clin Cancer Res 12: 1501-1506.
5. Fornaro M, Dell'Arciprete R, Stella M, Bucci C, Nutini M, et al. (1995) Cloning of the gene encoding TROP-2, a cell-surface glycoprotein expressed by human carcinomas. Int J Cancer 62: 610-618.
6. Trerotola M, Cantanelli P, Guerra E, Tripaldi R, Aloisi AL, et al. (2013) Upregulation of Trop-2 quantitatively stimulates human cancer growth. Oncogene 32 222-233.
7. Guerra E, Trerotola M, Aloisi AL, Tripaldi R, Vacca G, et al. (2013) The Trop-2 signalling network in cancer growth. Oncogene 32: 1594-1600.
8. Schön MP, Schön M, Mattes MJ, Stein R, Weber L, et al. (1993) Biochemical and immunological characterization of the human carcinoma- associated antigen MH 99/KS 1/4. Int J Cancer 55: 988-995. (Pubitemid 24005346)
9. Klein CE, Hartmann B, Schön MP, Weber L, Alberti S (1990) Expression of 38-kD cell-surface glycoprotein in transformed human keratinocyte cell lines, basal cell carcinomas, and epithelial germs. J Invest Dermatol 95: 74-82. (Pubitemid 20219447)
10. Zanna P, Trerotola M, Vacca G, Bonasera V, Palombo B, et al. (2007) Trop-1 is a novel cell growth stimulatory molecule that marks early stages of tumor progression. Cancer 110: 452-464. (Pubitemid 47121907)
11. Alberti S, Miotti S, Stella M, Klein CE, Fornaro M, et al. (1992) Biochemical characterization of Trop-2, a cell surface molecule expressed by human carcinomas: formal proof that the monoclonal antibodies T16 and MOv-16 recognize Trop-2. Hybridoma 11: 539-535.
12. Balzar M, Briaire-de Bruijn IH, Rees-Bakker HAM, Prins FA, Helfrich W, et al. (2001) Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions. Mol Cell Biol 21: 2570-2580. (Pubitemid 32222108)
13. Ambrogi F, Fornili M, Alberti S, Querzoli P, Piantelli M, et al. (2013) EpCAM Expression is an Indicator of Increased Incidence of Relapse in p53-Positive Breast Cancer Cancer Clin Oncol 2: 41-50.
14. Alberti S, Biganzoli E, Boracchi P, Ambrogi F, Querzoli P, et al. (2012) Cytoplasmic Trop-1 over-expression is associated with a favourable outcome in node-positive breast cancer patients. Jpn J Clin Oncol 42: 1128-1137.
15. Spizzo G, Obrist P, Ensinger C, Theurl I, Dunser M, et al. (2002) Prognostic significance of Ep-CAM and Her-2/neu overexpression in invasive breast cancer. Int J Cancer 98: 883-888. (Pubitemid 34286685)
16. Ripani E, Sacchetti A, Corda D, Alberti S (1998) The human Trop-2 is a tumor-associated calcium signal transducer. Int J Cancer 76: 671-676. (Pubitemid 28243939)
17. Stoyanova T, Goldstein AS, Cai H, Drake JM, Huang J, et al. (2012) Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via beta-catenin signaling. Genes Dev 26: 2271-2285.
18. Alberti S, Herzenberg LA (1988) DNA methylation prevents transfection of genes for specific surface antigens. Proc Natl Acad Sci USA 85: 8391-8394. (Pubitemid 19024982)
19. Alberti S, Nutini M, Herzenberg LA (1994) DNA methylation prevents the amplification of TROP1, a tumor associated cell surface antigen gene. Proc Natl Acad Sci USA 91: 5833-5837. (Pubitemid 24188236)
20. Querzoli P, Coradini D, Pedriali M, Boracchi P, Ambrogi F, et al. (2010) An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. Br J Cancer 103: 1835-1839.
21. Marubini E, Valsecchi MG (1995) Analyzing survival data from clinical trials and observational studies. Chichester.
22. Makuch RW (1982) Adjusted survival curve estimation using covariates. J Chronic Dis 35: 437-443.
23. Trerotola M, Jernigan D, Liu Q, Siddiqui J, Fatatis A, et al. (2013) Trop-2 promotes prostate cancer metastasis by modulating β1 integrin functions. Cancer Res 73: 3155-3167.
24. Lin H, Huang JF, Qiu JR, Zhang HL, Tang XJ, et al. (2012) Significantly upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of invasive ductal breast cancer. Exp Mol Pathol.
25. Guerra E, Trerotola M, Dell' Arciprete R, Bonasera V, Palombo B, et al. (2008) A bi-cistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer. Cancer Res 68: 8113-8121.
26. Mirza AN, Mirza NQ, Vlastos G, Singletary SE (2002) Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years. Ann Surg 235: 10-26. (Pubitemid 34062395)
27. Duffy MJ (2006) Estrogen receptors: role in breast cancer. Crit Rev Clin Lab Sci 43: 325-347.
28. Bardou VJ, Arpino G, Elledge RM, Osborne CK, Clark GM (2003) Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J Clin Oncol 21: 1973-1979. (Pubitemid 46606386)
29. Hellemans P, van Dam PA, Weyler J, van Oosterom AT, Buytaert P, et al. (1995) Prognostic value of bcl-2 expression in invasive breast cancer. Br J Cancer 72: 354-360.
30. Biganzoli E, Boracchi P, Coradini D, Grazia Daidone M, Marubini E (2003) Prognosis in node-negative primary breast cancer: a neural network analysis of risk profiles using routinely assessed factors. Ann Oncol 14: 1484-1493. (Pubitemid 37304602)
31. Biganzoli E, Coradini D, Ambrogi F, Garibaldi JM, Lisboa P, et al. (2011) p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features. Jpn J Clin Oncol 41: 172-179.
32. Lipinski M, Parks DR, Rouse RV, Herzenberg LA (1981) Human trophoblast cell-surface antigens defined by monoclonal antibodies. Proc Natl Acad Sci USA 78: 5147-5150. (Pubitemid 12229690)